FDA Clears Clew Medical’s Screening Software for COVID-19 Patients
The FDA has granted Clew Medical an Emergency Use Authorization (EUA) for its CLEWICU predictive screening software for adult COVID-19 patients in intensive care units (ICU).
The artificial intelligence-based tool uses patient data to help identify high-risk patients likely to be diagnosed with respiratory failure or hemodynamic instability.
The software runs on existing hospital computers and integrates with existing electronic health record systems and medical devices.
The FDA has said the tool will help provide better patient care and reduce the strain on ICU personnel.